(Q54069183)

English

Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10593935

Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth? (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10593935

1 reference

based on heuristic

inferred from title

author name string

Paka L

1

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10593935

Goldberg IJ

2

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10593935

Obunike JC

3

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10593935

Choi SY

4

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10593935

Saxena U

5

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10593935

Goldberg ID

6

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10593935

Pillarisetti S

7

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10593935

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10593935

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10593935

274

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10593935

51

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10593935

36403-36408

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10593935

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Lysolecithin-induced alteration of subendothelial heparan sulfate proteoglycans increases monocyte binding to matrix

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Relationship between perlecan and tropoelastin gene expression and cell replication in the developing rat pulmonary vasculature

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Proliferation and the monoclonal origins of atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Structural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor-beta via a nuclear factor 1-binding element

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Developmental regulation of perlecan gene expression in aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Binding of beta-VLDL to heparan sulfate proteoglycans requires lipoprotein lipase, whereas ApoE only modulates binding affinity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Heparinase III limits rat arterial smooth muscle cell proliferation in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Suppression by heparin of smooth muscle cell proliferation in injured arteries

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Apolipoprotein E containing high density lipoprotein stimulates endothelial production of heparan sulfate rich in biologically active heparin-like domains. A potential mechanism for the anti-atherogenic actions of vascular apolipoprotein e

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Arterial heparan sulfate proteoglycans inhibit vascular smooth muscle cell proliferation and phenotype change in vitro and neointimal formation in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Structural characterization of heparan sulfate proteoglycan subclasses isolated from bovine aortic endothelial cell cultures

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Characterization of proteoglycans synthesized by cultured corneal fibroblasts in response to transforming growth factor beta and fetal calf serum

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Basement-membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Heparin-like molecules regulate the number of epidermal growth factor receptors on vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Perlecan in human bone marrow: a growth-factor-presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Heparan sulfate proteoglycans mediate a potent inhibitory signal for migration of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Thrombin reduces large heparan sulfate proteoglycan molecules in cultured vascular endothelial cell layers through inhibition of core protein synthesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Molecular interactions of the syndecan core proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Identifiers

10.1074/JBC.274.51.36403

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10593935

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10593935

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54069183&oldid=2165487365"